The government has launched a review to consider how ground-breaking developments in genomics and digital technology might speed up patient access to innovative medicines, devices and diagnostics.
The Innovative Medicine and MedTech Review—launched by the Department of Health and the Department for Business, Innovation and Skills—will examine how recent developments in the field could speed up access to innovative products. It will also look at how closer collaboration between companies and regulatory bodies could enable faster assessment of technologies; the role that charities and patient groups can play; and what more can be to to promote the rapid adoption of important innovations into clinical practice.
The review coincides with a government announcement of £63 million of industry investment in life sciences in the UK.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.